Bioscan is a leading developer of advanced instrumentation for the detection, synthesis, and imaging of Radiolabeled Compounds used in four areas… • Life Science Research • Molecular Imaging • Pharmaceutical Development • Nuclear Medicine Bioscan is a leading provider of SPECT (Single Photon Emission Computed Tomography) and PET (Positron Emission Tomography) imaging systems for preclinical applications. Our tools enable researchers, pharmaceutical and biotech organizations to improve their drug development research using in vivo animal models. Our patented technology improves screening of drug pipeline candidates over classic in vitro methods by providing more relevant biological data, more consistency, as well as reduced cost and complexity. The unique imaging acuity of our products also makes it possible to translate research results from mouse models of human diseases to human clinical trials – driving increased speed to market for drugs. Bioscan is also a supplier of innovative instruments for radioisotope detection and analysis in life science, pharmaceutical and nuclear medicine research applications. As an expansion of its involvement in nuclear medicine, Bioscan now provides a variety of automated synthesis modules for the production of PET (F-18 & C-11) radiopharmaceuticals. Our analytical instruments provide solutions to both chemical purity and quality control in many applications involving radio-TLC, radio-HPLC, and isotope detection.
The AR-2000 radio-TLC Imaging Scanner has become the industry ‘Gold Standard’ in the detection of radiolabeled compounds in TLC plates…and also in the purity analysis of [18F] FDG Bioscan’s AR-2000 system provides direct digital counting of all radioisotopes, including high-energy positron emitters and low energy betas--such as tritium (3H)--without the need to exchange detectors. AR-2000’s design guarantees quantitative accur…
The new Bioscan BioFLECT 400 is the first in vivo optical imaging system offering true 360° fluorescence tomography. BioFLECT uses the photon emission data acquired from 360° and a state-of-the-art 3D reconstruction engine to quantitatively reconstruct the 3D spatial distribution of fluorescent probes in live animals. This approach yields superior, consistent resolution, sensitivity and quantitation throughout the subject. The…
BioFLECT™ In Vivo Preclinical Imager - The Only True 360° Tomographic Optical Imager With the launch of the BioFLECT, Bioscan will enable researchers to realize the full potential of in vivo optical imaging for the first time. With BioFLECT’s true 360° tomographic system, researchers will no longer have to choose between imaging only near the surface of the subject or partial tomography solutions that distort the subject or c…
